Raytech Holding Ltd

Raytech Holding Limited operates in the personal care electrical appliances industry, focusing on the sourcing and wholesaling of such products for international brand owners, with manufacturing outsourced to external manufacturers. Since fiscal year 2026, the company has also expanded into providing product design and development services, project advisory services, and marketing solutions services. The industry is highly competitive, with competition based on brand recognition, product quality, price, and innovation, and the company competes with large international personal care electronic design and development organizations, as well as small firms and independent contractors.

The company's primary competitors include large international personal care electronic design and development organizations that offer niche products and services similar to those offered by Raytech, as well as small firms and independent contractors focusing on specialized products and services. Some competitors have significantly more financial resources, a larger national or international presence, larger professional staff, and greater brand recognition. The company's competitive advantages include its long-standing relationships with key customers such as Koizumi Seiki Corp., a Japanese company with over 300 years of history, and its reliance on a related-party manufacturer, Zhongshan Raytech, which provides manufacturing collaboration. For the year ended March 31, 2026, one customer accounted for 62.5% of total revenues ¹, and payments to Zhongshan Raytech accounted for 62.1% of total purchases ².

The company generates revenue through the sourcing and wholesaling of personal care electrical appliances, with manufacturing outsourced to external manufacturers, and since fiscal 2026, through the provision of product design and development services, project advisory services, and marketing solutions services. Revenue is derived from sales of products, sales of tooling, and service income from these three service lines. The primary customer segments are international brand owners, with a significant portion of revenues concentrated among a few major customers, including Koizumi Seiki Corp. and a U.S. home appliance manufacturer. The company does not have any production facilities of its own and relies entirely on external manufacturers, primarily Zhongshan Raytech, a related party.

The company's product lines are organized into several series: Hair Styling Series, Trimmer Series, Nail Care Series, Eyelash Curler, and Other Personal Care Appliances. For the year ended March 31, 2026, the Hair Styling Series generated revenue of HKD 17,606,000 ³, the Trimmer Series generated HKD 8,476,000 ⁴, the Nail Care Series generated HKD 1,039,000 ⁵, the Eyelash Curler generated HKD 1,000 ⁶, and Other Personal Care Appliances generated HKD 1,000 ⁷. Sales of tooling generated HKD 1,000 ⁸ for the same period. The company also offers service income from three lines: product design and development services, project advisory services, and marketing solutions services. For the year ended March 31, 2026, service income from product design and development was HKD 1,000 ⁹, from project advisory was HKD 1,000 ¹⁰, and from marketing solutions was HKD 1,000 ¹¹.

On December 23, 2025, the company's subsidiary Raytech Innovation Limited agreed to acquire 100% of the issued share capital of Worry free Group (Hong Kong) Limited for an aggregate consideration of US$6,099,000 ¹², comprising US$4,099,000 ¹³ in cash and a US$2,000,000 ¹⁴ promissory note bearing interest at 2% per annum ¹⁵ and maturing on the second anniversary of its issuance. On September 24, 2024, the Board of Directors adopted, and on October 23, 2024, shareholders approved, the 2024 Equity Incentive Plan, which authorizes the issuance of up to 2,500,000 ¹⁶ Ordinary Shares. On November 7, 2025, the company effected a sixteen-for-one share consolidation of its ordinary shares. In June 2026, the company completed a registered direct offering under its Form F-3 shelf registration statement, which raised net proceeds of approximately US$6.08 million ¹⁷.

For the fiscal year ended March 31, 2026, total revenues were HKD 27,125,000 ¹⁸, compared to HKD 37,040,000 ¹⁹ for the fiscal year ended March 31, 2025, representing a decline. Net income for fiscal 2026 was HKD 1,000 ²⁰, compared to HKD 1,000 ²¹ for fiscal 2025. The company recorded net cash used in operating activities of HKD 14,511,287 ²² for fiscal 2026. Total accounts receivable increased to HKD 67,775,993 ²³ as of March 31, 2026, from HKD 8,144,307 ²⁴ as of March 31, 2025. The company's operating cash flow for fiscal 2026 was negative, and it has relied on external financing, including the June 2026 registered direct offering, to fund working capital.

The company is expanding its strategic focus into the personal health care electronics sector, which involves services relating to the design, development, and consultation of personal health care electronic products. This business line is relatively new, and the company has limited operating history in this sector. The expansion may require significant expenditures, including costs associated with research and development, product design, regulatory compliance, testing, marketing, and working capital. The company may not successfully develop or commercialize products or services in this area, and there can be no assurance that this expansion will generate meaningful revenues or achieve profitability.

The company is pursuing growth through its newly launched service businesses, including product design and development, project advisory, and marketing solutions services, which commenced or were acquired during fiscal 2026. These services expanded significantly toward the end of the fiscal year, resulting in a substantial increase in accounts receivable to HKD 67,775,993 ²⁵ as of March 31, 2026. The company also completed the acquisition of Worry free Group (Hong Kong) Limited on December 23, 2025, for an aggregate consideration of US$6,099,000 ²⁶, which is expected to contribute to the company's service offerings and growth in the personal health care electronics sector.

The filing does not provide specific margin or cost outlook, margin trajectory, cost structure evolution, or efficiency or restructuring targets with exact figures.

The company relies on external manufacturers for the production of all of its personal care electrical appliances products, with no production facilities or production lines of its own. The company's major manufacturer is Zhongshan Raytech, a related party located in Zhongshan, mainland China, which accounted for 62.1% of total purchases for the year ended March 31, 2026 ²⁷. The company does not currently have other reliable alternatives or replacements for Zhongshan Raytech. The company's operations are based in Hong Kong, and it does not have any subsidiary or VIE structure in mainland China. The company has identified material weaknesses in internal control over financial reporting and is actively implementing measures to improve, including hiring more qualified staff and setting up a financial and system control framework with formal documentation of policies and controls.

The company's 2024 Equity Incentive Plan authorizes the issuance of up to 2,500,000 ²⁸ Ordinary Shares. The company completed a registered direct offering in June 2026 under its Form F-3 shelf registration statement, raising net proceeds of approximately US$6.08 million ²⁹. The company does not intend to pay dividends for the foreseeable future, as it currently intends to retain all available funds and future earnings for the operation and expansion of its business. The filing does not disclose specific R&D spending levels, capital expenditure plans, or share repurchase authorization amounts.

The company faces structural headwinds including substantial customer concentration, with one customer accounting for 62.5% of total revenues for the year ended March 31, 2026 ³⁰, and heavy reliance on one manufacturer, Zhongshan Raytech, which accounted for 62.1% of total purchases for the same period ³¹. The company's expansion into the personal health care electronics sector is relatively new and may require significant investment without assurance of adequate return. The company also faces risks related to changes in U.S. and international trade policies, particularly with regard to China, including tariffs and export control restrictions, which could adversely impact its business and operating results.

The company faces regulatory and political risks associated with conducting business in Hong Kong, including the potential impact of the Hong Kong National Security Law and the Hong Kong Autonomy Act. The company also faces uncertainties regarding whether it will be required to obtain approvals from mainland China and Hong Kong authorities to list additional securities on U.S. exchanges or offer securities in the future. The company's ability to move money out of Hong Kong to distribute earnings and pay dividends could be subject to future restrictions imposed by the PRC government. Additionally, the company's auditor is based in Singapore and is subject to PCAOB inspections, but there is no guarantee that future audit reports will be prepared by auditors inspected by the PCAOB, which could lead to delisting under the HFCA Act.

The company faces material risks from substantial customer concentration, with one customer accounting for 62.5% of total revenues for the year ended March 31, 2026 ³², and heavy reliance on one manufacturer, Zhongshan Raytech, which accounted for 62.1% of total purchases for the same period ³³. The company's expansion into the personal health care electronics sector is relatively new and may require significant investment without assurance of adequate return, and the company may not successfully develop or commercialize products in this area. The company's acquisition of Worry free Group (Hong Kong) Limited for an aggregate consideration of US$6,099,000 ³⁴ exposes it to integration and financial risks, including potential impairment of goodwill and the need to service a US$2,000,000 ³⁵ promissory note bearing interest at 2% per annum ³⁶. The company's operating cash flow for fiscal 2026 was negative, with net cash used in operating activities of HKD 14,511,287 ³⁷, and total accounts receivable increased to HKD 67,775,993 ³⁸ as of March 31, 2026, creating liquidity risk if these receivables are not collected in a timely manner or if external financing is not available on acceptable terms.

Management's message emphasizes the company's strategic expansion into the personal health care electronics sector and the acquisition of Worry free Group (Hong Kong) Limited as key initiatives for future growth. The company acknowledges the risks associated with this expansion, including the need for significant investment and the possibility of not realizing an adequate return. Management also highlights the importance of retaining key personnel, particularly the founder, CEO, and director Mr. Ching Tim Hoi, and managing relationships with key customers and manufacturers. The company is focused on improving internal controls over financial reporting, having identified material weaknesses, and is actively implementing measures to address them, including hiring more qualified staff and establishing a formal financial and system control framework.